[Antidiabetic properties of high molecular weight heparin-adenosine triphosphate complex].
Repeated intramuscular administration of the heparin-adenosine triphosphate (ATP) complex or ATP increased plasma anticoagulant and fibrinolytic activities and depressed the anticoagulation system in rats at the age of 10-11 months. Diabetogenic dose of alloxan induced no diabetes mellitus in such animals.
Ul'ianov
A M
AM
Liapin
L A
LA
Pastorova
V E
VE
D000255:Adenosine Triphosphate / Q000008:administration & dosage*; D000496:Alloxan / Q000008:administration & dosage; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage*; D003921:Diabetes Mellitus, Experimental / Q000517:prevention & control*; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage*; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D008970:Molecular Weight; D051381:Rats; D011922:Rats, Mutant Strains
D000925:Anticoagulants; D007004:Hypoglycemic Agents; D000496:Alloxan; D000255:Adenosine Triphosphate; D006493:Heparin